Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Thibault

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 28, 2024
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessmentMariana Mirabel, Assié Eslami, Constance Thibault, et al.
European Urology Oncology|February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical ReviewFrancesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
Annals of Surgical Oncology|May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer CommitteePierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
BJUI Compass|July 21, 2025
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patientsIlfad Blazevic, Aude Fléchon, Géraldine Pignot, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric studyEdwige Baudry, Natacha Naoun, Edouard Auclin, et al.
Clinical Genitourinary Cancer|February 7, 2026
Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell CarcinomaAlia Harba, Fabien Moinard-Butot, Edouard Auclin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2023
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)Constance Thibault, Aude Fléchon, Laurence Albiges, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2018
Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancerConstance Thibault, Jean-Christophe Eymard, Alison Birtle, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective studyManon de Vries-Brilland, Marine Gross-Goupil, Valérie Seegers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 TrialNadine Houédé, Thierry Chevallier, François Audenet, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 28, 2024
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessmentMariana Mirabel, Assié Eslami, Constance Thibault, et al.
European Urology Oncology|February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical ReviewFrancesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
Annals of Surgical Oncology|May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer CommitteePierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
BJUI Compass|July 21, 2025
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patientsIlfad Blazevic, Aude Fléchon, Géraldine Pignot, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric studyEdwige Baudry, Natacha Naoun, Edouard Auclin, et al.
Clinical Genitourinary Cancer|February 7, 2026
Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell CarcinomaAlia Harba, Fabien Moinard-Butot, Edouard Auclin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2023
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24)Constance Thibault, Aude Fléchon, Laurence Albiges, et al.
European Journal of Cancer (Oxford, England : 1990)|April 12, 2018
Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancerConstance Thibault, Jean-Christophe Eymard, Alison Birtle, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective studyManon de Vries-Brilland, Marine Gross-Goupil, Valérie Seegers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 TrialNadine Houédé, Thierry Chevallier, François Audenet, et al.
Pageof 11